[Management of side effects of endocrine treatment for prostate cancer].
Kamoto
Toshiyuki
T
Department of Urology, Kyoto University Graduate School of Medicine.
D000726:Androgen Antagonists / Q000009:adverse effects; D002369:Castration / Q000009:adverse effects; D005262:Feminization / Q000209:etiology / Q000628:therapy; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D019584:Hot Flashes / Q000209:etiology / Q000628:therapy; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000209:etiology / Q000628:therapy; D011471:Prostatic Neoplasms / Q000628:therapy*; D011788:Quality of Life; D012735:Sexual Dysfunction, Physiological / Q000209:etiology / Q000628:therapy
D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone